Inventor profile of:

Yang Li

City:

Mountain View, California

Country:

United States

Published Applications:

55

Last publication date:

2026-05-21

Top Assignees for applications by Yang Li

The entities that hold a legal rights for patent applications filed by inventor Li Yang:

Recent patent applications by Li Yang

Yang Li from Mountain View, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-21
US20260139018A1
Chemistry; metallurgy

MODULATION OF WNT SIGNALLING IN CORNEAL DISORDERS

#2 | 2025-10-09
US20250313616A1
Chemistry; metallurgy

MODULATION OF WNT SIGNALLING IN OCULAR DISORDERS

#3 | 2025-07-10
US20250223368A1
Chemistry; metallurgy

WNT SURROGATE MOLECULES AND USES THEREOF

#4 | 2025-05-29
US20250171509A1
Chemistry; metallurgy

LIVER-SPECIFIC WNT SIGNAL ENHANCING MOLECULES AND USES THEREOF

#5 | 2025-05-22
US20250163160A1
Chemistry; metallurgy

Human Antigen Binding Proteins That Bind Beta-Klotho, FGF Receptors and Complexes Thereof

#6 | 2025-02-13
US20250051459A1
Chemistry; metallurgy

WNT-SURROGATE AGENTS AND METHODS FOR LACRIMAL GLAND REGENERATION

#7 | 2025-02-13
US20250051457A1
Chemistry; metallurgy

ASGR INHIBITORS

#8 | 2024-11-28
US20240391991A1
Chemistry; metallurgy

MODULATION OF WNT SIGNALLING IN PULMONARY DISORDERS

#9 | 2024-11-07
US20240368287A1
Chemistry; metallurgy

ANTI-FRIZZLED ANTIBODIES AND METHODS OF USE

#10 | 2024-08-22
US20240279303A1
Chemistry; metallurgy

TISSUE-SPECIFIC WNT SIGNAL ENHANCING MOLECULES AND USES THEREOF

#11 | 2024-08-08
US20240262918A1
Chemistry; metallurgy

FC-MODIFIED WNT SURROGATE MOLECULES AND USES THEREOF

#12 | 2024-05-09
US20240150473A1
Chemistry; metallurgy

MODULATION OF WNT SIGNALING IN GASTROINTESTINAL DISORDERS

#13 | 2024-05-09
US20240150458A1
Chemistry; metallurgy

ANTI-LRP5/6 ANTIBODIES AND METHODS OF USE

#14 | 2024-05-02
US20240141049A1
Chemistry; metallurgy

Wnt surrogate molecules and uses thereof

#15 | 2023-11-23
US20230374090A1
Chemistry; metallurgy

Liver-specific Wnt signal enhancing molecules and uses thereof

#16 | 2023-09-21
US20230295347A1
Chemistry; metallurgy

WNT RECEPTOR-SPECIFIC COMPOUND AND METHOD RELATING THERETO

#17 | 2023-05-04
US20230138045A1
Chemistry; metallurgy

WNT SUPER AGONISTS

#18 | 2023-05-04
US20230137351A1
Chemistry; metallurgy

BISPECIFIC OR BIPARATOPIC ANTIGEN BINDING PROTEINS AND USES THEREOF

#19 | 2022-09-01
US20220275095A1
Chemistry; metallurgy

MONOSPECIFIC ANTI-FRIZZLED ANTIBODIES AND METHODS OF USE

#20 | 2022-06-23
US20220195053A1
Chemistry; metallurgy

MODULATION OF WNT SIGNALING IN GASTROINTESTINAL DISORDERS

#21 | 2022-06-09
US20220175884A1
Human necessities

MODULATION OF WNT SIGNALING IN AUDITORY DISORDERS

#22 | 2022-04-14
US20220112278A1
Chemistry; metallurgy

MODULATION OF WNT SIGNALLING IN OCULAR DISORDERS

#23 | 2022-03-03
US20220064337A1
Chemistry; metallurgy

ANTIGEN BINDING FORMATS FOR RECEPTOR COMPLEXES

#24 | 2021-12-09
US20210380678A1
Chemistry; metallurgy

TISSUE-SPECIFIC WNT SIGNAL ENHANCING MOLECULES AND USES

#25 | 2021-09-23
US20210292422A1
Chemistry; metallurgy

MULTI-SPECIFIC WNT SURROGATE MOLECULES AND USES THEREOF

#26 | 2021-06-03
US20210163601A1
Chemistry; metallurgy

ASGR INHIBITORS

#27 | 2021-04-15
US20210108212A1
Chemistry; metallurgy

RNAi constructs for inhibiting ASGR1 expression and methods of use thereof

#28 | 2021-03-25
US20210087280A1
Chemistry; metallurgy

Anti-frizzled antibodies and methods of use

#29 | 2021-03-18
US20210079089A1
Chemistry; metallurgy

Anti-LRP5/6 antibodies and methods of use

#30 | 2021-03-04
US20210064865A1
Physics

System and method of performing patch-based document segmentation for information extraction

#31 | 2020-10-15
US20200325200A1
Chemistry; metallurgy

METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING GROWTH DIFFERENTIATION FACTOR 15 (GDF-15)

#32 | 2020-10-01
US20200308287A1
Chemistry; metallurgy

WNT surrogate molecules and uses thereof

#33 | 2020-07-09
US20200216546A1
Chemistry; metallurgy

Human antigen binding proteins that bind β-klotho, FGF receptors and complexes thereof

#34 | 2020-02-13
US20200048324A1
Chemistry; metallurgy

Tissue-specific Wnt signal enhancing molecules and uses thereof

#35 | 2019-10-10
US20190309306A1
Chemistry; metallurgy

RNAi constructs for inhibiting ASGR1 expression and methods of use thereof

#36 | 2019-08-15
US20190248906A1
Chemistry; metallurgy

Antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptor

#37 | 2019-08-15
US20190248902A1
Chemistry; metallurgy

Methods of treating cardiovascular disease with an anti-ASGR antibody or binding fragments thereof

#38 | 2019-03-19
US14865120
Physics

Cross-device interaction through user-demonstrated gestures

#39 | 2017-06-29
US20170183412A1
Chemistry; metallurgy

Human Antigen Binding Proteins That Bind To a Complex Comprising beta-Klotho and an FGF Receptor

#40 | 2017-03-30
US20170088620A1
Chemistry; metallurgy

Methods of treating cardiovascular disease with an ASGR inhibitor

#41 | 2017-01-19
US20170015750A1
Chemistry; metallurgy

Human antigen binding proteins that bind β-Klotho, FGF receptors and complexes thereof

#42 | 2016-08-25
US20160248562A1
Electricity

Channel-state-information reference signals for advanced wireless systems

#43 | 2016-05-26
US20160145351A1
Chemistry; metallurgy

Human antigen binding proteins that bind β-klotho, FGF receptors and complexes thereof

#44 | 2016-01-28
US20160024196A1
Chemistry; metallurgy

Secreted frizzle-related protein 5 (SFRP5) binding proteins

#45 | 2016-01-14
US20160008439A1
Human necessities

Method of treating metabolic disorders using PLA2G12A polypeptides and PLA2G12A mutant polypeptides

#46 | 2015-10-29
US20150307575A1
Chemistry; metallurgy

Method of treating or ameliorating metabolic disorders using growth differentiation factor 15 (GDF-15)

#47 | 2014-08-14
US20140227265A1
Chemistry; metallurgy

METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING CLEC-2

#48 | 2014-07-03
US20140189893A1
Physics

METHOD OF IDENTIFYING COMPOUNDS THAT SPECIFICALLY MODULATE THE INTERACTION OF FGFR1 AND BETA KLOTHO

#49 | 2013-08-01
US20130197191A1
Chemistry; metallurgy

Binding Proteins That Bind to Human FGFR1c, Human Beta-Klotho and Both Human FGFR1c and Human Beta-Klotho

#50 | 2013-06-06
US20130143796A1
Chemistry; metallurgy

CHIMERIC POLYPEPTIDES AND USES THEREOF

#51 | 2013-05-23
US20130129725A1
Human necessities

Human FGF receptor and β-Klotho binding proteins

#52 | 2012-12-27
US20120328616A1
Chemistry; metallurgy

Human antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptor

#53 | 2011-06-23
US20110150901A1
Chemistry; metallurgy

Binding proteins that bind to human FGFR1C, human β-klotho and both human FGFR1C and human β-klotho

#54 | 2011-06-09
US20110135657A1
Chemistry; metallurgy

Human antigen binding proteins that bind β-Klotho, FGF receptors and complexes thereof

#55 | 2010-12-23
US20100323954A1
Chemistry; metallurgy

Chimeric polypeptides and uses thereof

InventorID:

260825 ⎘